MDD
Axsome’s late-stage study of experimental depression drug misses main trial goal
March 31, 2020Manufacturing and Production Depressive Disorder, MDD, depression, migraine
Axsome Therapeutics reported on Monday that its Phase 3 study of its experimental depression drug missed its main trial goal. …
European Commission authorises Janssen’s anti-depressant Spravato
December 23, 2019Sales and Marketing Janssen, MDD, Nasal Spray, TRD, depression, mental health
The European Commission has approved Janssen’s nasal spray Spravato (esketamine), which is used to treat major depressive disorder (MDD) that …
Oral contraceptive use as teenager linked to depression as an adult, study says
August 29, 2019Research and Development MDD, depression, hormones, oral contraceptives, psychiatry, psychology
Women who have used oral contraceptives as teenagers are more likely to experience depression later in life, according to a …
Minerva’s insomnia treatment beats Ambien in Phase 2b trial
June 25, 2019Manufacturing and Production MDD, Minerva Neurosciences, Placebo, ambien, insomnia, pharma, zolpidem
Massachusetts-based firm Minerva Neurosciences has announced that its sleeping pill seltorexant beat both Sanofi’s Ambien (zolpidem) and placebo in treating …
Pfizer releases new data for Pristiq
May 9, 2012Research and Development, Sales and Marketing Effexor, MDD, Pfizer, Pristiq, antidepressant
Pfizer has released positive data for its established antidepressant Pristiq, as it hopes to extend the use of the drug. …
Targacept cuts workforce
May 1, 2012Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept
The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
